Physician profile
John A Moss
NPI 1740273481
$995.18
in general payments reported to CMS, 2019-2025
8 companies · $93.00 in 2025
The $93.00 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.61 · 2021: $177 · 2022: $154 · 2023: $205 · 2024: $267 · 2025: $93.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $608.00 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Cook Medical LLC | $124.62 | 2022-2025 | Zilver Ptx |
| Depuy Synthes Sales INC. | $97.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $74.15 | 2021-2022 | |
| Cardiva Medical, INC. | $25.72 | 2022 | |
| United Therapeutics Corporation | $24.85 | 2023 | Tyvaso |
| Shockwave Medical, INC | $20.83 | 2022 | |
| Integra Lifesciences Corporation | $19.40 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.